HLS Therapeutics Inc's total assets for Q4 2024 were $159.90M, a decrease of -6.89% from the previous quarter. TSE:HLS total liabilities were $88.56M for the fiscal quarter, a -4.16% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.